Narcolepsy Meeting Focuses On Symptoms, But Some Urge Attention To Underlying Cause

In the fourth meeting conducted under FDA’s patient-focused drug development initiative, dozens of narcoleptics talked about the symptoms they would like new therapies to address. However, some patients said new drugs should go beyond providing mere symptom relief and target the root of the condition.